Stay updated on V114-004 Safety/Immunogenicity in Healthy Adults & Infants Clinical Trial
Sign up to get notified when there's something new on the V114-004 Safety/Immunogenicity in Healthy Adults & Infants Clinical Trial page.

Latest updates to the V114-004 Safety/Immunogenicity in Healthy Adults & Infants Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe web page has been updated to version 2.15.0, replacing the previous version 2.14.4.SummaryDifference0.2%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1.0%
- Check88 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference1.0%
Stay in the know with updates to V114-004 Safety/Immunogenicity in Healthy Adults & Infants Clinical Trial
Enter your email address, and we'll notify you when there's something new on the V114-004 Safety/Immunogenicity in Healthy Adults & Infants Clinical Trial page.